Mutated pseudomonas exotoxins with reduced antigenicity

Details for Australian Patent Application No. 2012216642 (hide)

Owner The Government of The United States of America, as represented by the Secretary of Health and Human Services National Institutes of Health

Inventors Pastan, Ira H.; Onda, Masanori; Nagata, Satoshi; Fitzgerald, David; Kreitman, Robert; Lee, Byungkook

Agent Pizzeys

Pub. Number AU-A-2012216642

Parent 2006275865

Filing date 28 August 2012

Wipo publication date 27 September 2012

International Classifications

C07K 14/195 Peptides having more than 20 amino acids - from bacteria

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 14/21 Peptides having more than 20 amino acids

C07K 19/00 Hybrid peptides

Event Publications

20 September 2012 Complete Application Filed

27 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216642

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216643-Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs

2012216641-Novel immunogenic epitopes for immunotherapy